Clinical Trial

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Study acronym: RESTORE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2029-03 -> 2027-11 2026-05-29
minor Completion moved earlier: 2033-07 -> 2027-11 2026-05-29
Trial Details
NCT Number NCT06777368
Lead Sponsor Medtronic Cardiovascular
Conditions Aortic Stenosis
Enrollment 225 participants
Start Date 2025-02-06
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-28